About
Tumor Testing & Banking
Areas of Focus
Categories
Non-PharmaceuticalNJ, NY, PA
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
126
By Phase
NA: 2
By Status
COMPLETED: 2TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
Today
Hover over trial bars to see details
Recent Trials
NCT02720796Lead Sponsor
Patient-Derived Xenograft (PDX) Modeling in Adult Patients With Metastatic or Recurrent Sarcoma
NATerminated
17 participants
Started: Nov 30, 2015 · Completed: Nov 30, 2017
NCT02752932Collaborator
TumorGraft- Guided Therapy for Improved Outcomes in Head and Neck Squamous Cell Cancer- A Feasibility Study
NACompleted
41 participants
Started: Nov 30, 2015 · Completed: Oct 12, 2017
NCT02247037Collaborator
Patient-derived Xenograft (PDX) Modeling of Treatment Response for Triple Negative Breast Cancer
N/ACompleted
68 participants
Started: Jul 31, 2014 · Completed: Jan 22, 2019
Locations (1)
Headquarters
Hackensack, NJ, United States
Map
Loading map...